-+ 0.00%
-+ 0.00%
-+ 0.00%

AstraZeneca's third-quarter revenue rose 7% due to growth in the oncology business.

Zhitongcaijing·10/30/2026 07:17:25
Listen to the news
AstraZeneca's third-quarter revenue rose 7% due to growth in the oncology business.